1. Home
  2. VRAX vs CLRO Comparison

VRAX vs CLRO Comparison

Compare VRAX & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • CLRO
  • Stock Information
  • Founded
  • VRAX 2013
  • CLRO 1983
  • Country
  • VRAX United Kingdom
  • CLRO United States
  • Employees
  • VRAX N/A
  • CLRO N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CLRO Radio And Television Broadcasting And Communications Equipment
  • Sector
  • VRAX Health Care
  • CLRO Technology
  • Exchange
  • VRAX Nasdaq
  • CLRO Nasdaq
  • Market Cap
  • VRAX 17.2M
  • CLRO 13.9M
  • IPO Year
  • VRAX 2022
  • CLRO N/A
  • Fundamental
  • Price
  • VRAX $2.80
  • CLRO $0.57
  • Analyst Decision
  • VRAX
  • CLRO
  • Analyst Count
  • VRAX 0
  • CLRO 0
  • Target Price
  • VRAX N/A
  • CLRO N/A
  • AVG Volume (30 Days)
  • VRAX 13.0M
  • CLRO 66.0K
  • Earning Date
  • VRAX 11-06-2024
  • CLRO 11-07-2024
  • Dividend Yield
  • VRAX N/A
  • CLRO 86.49%
  • EPS Growth
  • VRAX N/A
  • CLRO N/A
  • EPS
  • VRAX N/A
  • CLRO N/A
  • Revenue
  • VRAX $156,419.00
  • CLRO $14,969,000.00
  • Revenue This Year
  • VRAX $5,169.18
  • CLRO N/A
  • Revenue Next Year
  • VRAX $66.97
  • CLRO N/A
  • P/E Ratio
  • VRAX N/A
  • CLRO N/A
  • Revenue Growth
  • VRAX 1727.11
  • CLRO N/A
  • 52 Week Low
  • VRAX $0.60
  • CLRO $0.53
  • 52 Week High
  • VRAX $9.00
  • CLRO $2.48
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 46.62
  • CLRO 49.30
  • Support Level
  • VRAX $2.40
  • CLRO $0.55
  • Resistance Level
  • VRAX $3.26
  • CLRO $0.61
  • Average True Range (ATR)
  • VRAX 0.75
  • CLRO 0.02
  • MACD
  • VRAX -0.31
  • CLRO 0.01
  • Stochastic Oscillator
  • VRAX 9.18
  • CLRO 76.50

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About CLRO ClearOne Inc. (DE)

ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.

Share on Social Networks: